Orange Book product · Generic (ANDA)
POTASSIUM CHLORIDE
POTASSIUM CHLORIDE
At a glance
Jun 16, 2023
Approved
Generic (ANDA)
Application
AB1
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 16, 2023
3 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
POTASSIUM CHLORIDE
Strength
10MEQ
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
AB1
Application
ANDA 216321
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of POTASSIUM CHLORIDE
- 2023POKONZABrand (NDA)
NDA 208019 · GENUS
- 1988MICRO-K LSBrand (NDA)
NDA 019561 · KV PHARM
- —MICRO-KBrand (NDA)
NDA 018238 · NESHER PHARMS
- 2025POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 219009 · ANDA REPOSITORY
- 2023POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 212816 · NOVITIUM PHARMA
- 2022POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 214108 · RUBICON RESEARCH
- 2022POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 213467 · GRANULES
- 2021POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 211667 · STRIDES PHARMA
- 2021POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 214686 · GRANULES
- 2019POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 209026 · PRINSTON INC
- 2019POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 210902 · AMNEAL
- 2019POTASSIUM CHLORIDEGeneric (ANDA)
ANDA 212183 · AJENAT PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
